Jerusalem artichoke inulin supplementation ameliorates hepatic lipid metabolism in type 2 diabetes mellitus mice by modulating the gut microbiota and fecal metabolome-Reference-Cited by-同舟云学术

Jerusalem artichoke inulin supplementation ameliorates hepatic lipid metabolism in type 2 diabetes mellitus mice by modulating the gut microbiota and fecal metabolome

Published:2022 Issue:22 Volume:13 Page:11503-11517
ISSN:2042-6496
Container-title:Food & Function
language:en
Short-container-title:Food Funct.

Author:

Li Jianpeng¹²^ORCID,Jia Siqiang¹²,Yuan Chao¹²,Yu Bin¹²,Zhang Zheng¹²,Zhao Meng¹²,Liu Pengfei¹²,Li Xia³,Cui Bo¹²^ORCID

Affiliation:

1. State Key Laboratory of Biobased Material and Green Papermaking, Qilu University of Technology, Shandong Academy of Sciences, Jinan 250353, China

2. School of Food Science and Engineering, Qilu University of Technology, Shandong Academy of Sciences, Jinan 250353, China

3. School of Bioengineering, Qilu University of Technology, Shandong Academy of Sciences, Jinan 250353, China

Abstract

The main focus of this study was on the protection mechanism of Jerusalem artichoke inulin (DI) against type 2 diabetes mellitus (T2DM) associated with abnormal hepatic lipid metabolism and gut microbiota dysfunction in T2DM mice.

Funder

National Key Research and Development Program of China

Key Technology Research and Development Program of Shandong

Natural Science Foundation of Shandong Province

Publisher

Royal Society of Chemistry (RSC)

Subject

General Medicine,Food Science

Link

http://pubs.rsc.org/en/content/articlepdf/2022/FO/D2FO02051C

Reference68 articles.

1. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition